-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on FibroBiologics, Lowers Price Target to $6

Benzinga·08/04/2026 10:15:25
Listen to the news
HC Wainwright & Co. analyst Matthew Caufield maintains FibroBiologics (NASDAQ:FBLG) with a Buy and lowers the price target from $8 to $6.